Unverified50% confidenceFactExact time

2024年多家制药公司已将AI生成的候选分子推入针对神经退行性疾病的临床试验阶段

1

Sources

50%

Confidence

Medium-term (~90 days)

Relevance

8/28/2026

First Seen

Valid until: 11/26/2026

Sources

Can Neck Lymphatic Surgery Reverse Alzheimer's? Analyzing the Scientific Hypothesis and Controversy

Related Entities

神经退行性疾病concept

Related Claims

UnverifiedInsilico Medicine于2023年将其AI设计的候选药物推进至临床II期试验，成为首个完全由AI设计并进入临床阶段的药物分子76% similar Unverified2023年FDA发布了AI/ML药物开发讨论文件，但仅是初步探索71% similar UnverifiedIn 2024, more than 40% of enterprises have begun introducing AI tools into their testing processes.69% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/810602

API

curl https://kongchang.com/api/v1/knowledge/claims/810602

MCP

get_claim(id=810602)